Milestone Pharmaceuticals Inc.
Total Trades
25
Buys
7
Sells
7
Largest Trade
N/A
Insiders
11
Institutional Funds
54
Inst. Value
$1M+
Activist Filings
32
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Bharucha David | Chief Medical Offi… | GRANT | N/A | 100K | — | Jan 28, 2026 |
| Bharucha David | Chief Medical Offi… | EXERCISE | N/A | 20K | — | Jan 28, 2026 |
| Bharucha David | Chief Medical Offi… | SELL | $100K–$500K | 70K | $2.25 | Jan 28, 2026 |
| Nelson Jeffrey Edward | COO | EXERCISE | N/A | 20K | — | Jan 28, 2026 |
| Nelson Jeffrey Edward | COO | SELL | $100K–$500K | 70K | $2.25 | Jan 28, 2026 |
| Nelson Jeffrey Edward | COO | GRANT | N/A | 100K | — | Jan 28, 2026 |
| Muller Lorenz | Chief Commercial O… | EXERCISE | N/A | 20K | — | Jan 28, 2026 |
| Muller Lorenz | Chief Commercial O… | GRANT | N/A | 100K | — | Jan 28, 2026 |
| Muller Lorenz | Chief Commercial O… | SELL | $100K–$500K | 65K | $2.25 | Jan 28, 2026 |
| Hasija Amit | CFO & EVP of Corp.… | GRANT | N/A | 100K | — | Jan 28, 2026 |
| Hasija Amit | CFO & EVP of Corp.… | SELL | $100K–$500K | 70K | $2.25 | Jan 28, 2026 |
| Hasija Amit | CFO & EVP of Corp.… | EXERCISE | N/A | 20K | — | Jan 28, 2026 |
| Oliveto Joseph | President and CEO | GRANT | N/A | 280K | — | Jan 28, 2026 |
| Oliveto Joseph | President and CEO | SELL | $100K–$500K | 168K | $2.24 | Jan 28, 2026 |
| Oliveto Joseph | President and CEO | EXERCISE | N/A | 67K | — | Jan 28, 2026 |
| Oliveto Joseph | President and CEO | SELL | $50K–$100K | 44K | $2.25 | Jan 9, 2026 |
| Bharucha David | Chief Medical Offi… | BUY | $15K–$50K | 10K | $4.74 | Dec 5, 2022 |
| Wills Robert James | Director | BUY | $50K–$100K | 15K | $4.93 | Oct 21, 2022 |
| Pasternak Richard C | Director | BUY | $50K–$100K | 10K | $5.20 | Oct 21, 2022 |
| Liebert Debra K. | Director | BUY | $50K–$100K | 14K | $5.28 | Oct 21, 2022 |
| TOMSICEK MICHAEL JOHN | Director | BUY | $50K–$100K | 15K | $5.32 | Oct 21, 2022 |
| RTW INVESTMENTS, LP | 10% Owner | SELL | $1M+ | 1.6M | $8.71 | Sep 9, 2022 |
| RTW INVESTMENTS, LP | 10% Owner | BUY | $1M+ | 1.6M | $8.71 | Sep 9, 2022 |
| TRUEX PAUL F | Director | BUY | $15K–$50K | 5K | $5.60 | Jun 2, 2022 |
| TRUEX PAUL F | Director | EXERCISE | $100K–$500K | 77K | $1.51 | Jun 2, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 54 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Propel Bio Management, LLC | 4.1M | $1M+ | SH |
| Simplify Asset Management Inc. | 1.5M | $1M+ | SH |
| Pathstone Holdings, LLC | 1.0M | $1M+ | SH |
| Lion Point Capital, LP | 755K | $1M+ | SH |
| TORONTO DOMINION BANK | 750K | $1M+ | SH |
| Stonepine Capital Management, LLC | 663K | $1M+ | SH |
| JANE STREET GROUP, LLC | 582K | $1M+ | SH |
| Point72 Asset Management, L.P. | 482K | $500K+ | SH |
| UBS Group AG | 438K | $500K+ | SH |
| Aptus Capital Advisors, LLC | 263K | $500K+ | SH |
| Squarepoint Ops LLC | 249K | $500K+ | SH |
| GSA CAPITAL PARTNERS LLP | 236K | $100K–$500K | SH |
| NOMURA HOLDINGS INC | 225K | $100K–$500K | SH |
| BNP PARIBAS FINANCIAL MARKETS | 222K | $100K–$500K | SH |
| GROUP ONE TRADING LLC | 195K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 176K | $100K–$500K | SH |
| LPL Financial LLC | 142K | $100K–$500K | SH |
| Valeo Financial Advisors, LLC | 131K | $100K–$500K | SH |
| ADAR1 Capital Management, LLC | 100K | $100K–$500K | SH |
| ADAR1 Capital Management, LLC | 100K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Dec 23, 2025
9.9%
8.9M shares
Trails Edge Capital Partners, LP
SC 13G/A · Nov 14, 2025
9.9%
9.0M shares
SC 13G/A · Nov 14, 2025
9.9%
9.2M shares
Adage Capital Management, L.P.
SC 13G · Nov 13, 2025
10.0%
8.7M shares
Trails Edge Capital Partners, LP
SC 13G · Jul 21, 2025
9.9%
8.8M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Apr 30, 2025
0.6%
322K shares
SC 13G/A · Apr 22, 2025
0.0%
0 shares
SC 13G/A · Feb 14, 2025
10.0%
5.6M shares
SC 13G/A · Feb 5, 2025
7.6%
4.1M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Oct 29, 2024
5.1%
2.7M shares
SC 13D/A · Jul 16, 2024
5.0%
2.7M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 15, 2024
2.8%
925K shares
SC 13G/A · Feb 14, 2024
10.0%
3.4M shares
SC 13G/A · Feb 10, 2024
4.1%
1.4M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Jan 29, 2024
5.2%
1.7M shares
SC 13D · Nov 9, 2023
5.0%
1.7M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 14, 2023
6.4%
2.2M shares
SC 13G/A · Feb 14, 2023
2.0%
699K shares
SC 13G/A · Feb 14, 2023
1.3%
460K shares
SC 13G · Jan 19, 2023
8.0%
2.8M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Jan 18, 2023
5.5%
1.9M shares
Integrated Core Strategies (US) LLC
SC 13G · Oct 31, 2022
5.3%
1.6M shares
SC 13D/A · Oct 24, 2022
4.6%
1.4M shares
SC 13D/A · Sep 26, 2022
7.0%
2.1M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Sep 20, 2022
6.9%
2.1M shares
SC 13G/A · Feb 14, 2022
0.224 shares
SC 13G/A · Feb 14, 2022
5.9%
1.8M shares
SC 13G/A · Feb 14, 2022
7.5%
2.2M shares
SC 13G/A · Feb 14, 2022
14.4%
4.3M shares
SC 13G/A · Feb 11, 2022
8.7%
2.6M shares